Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force

Davide Angioni, J. Delrieu, O. Hansson, H. Fillit, P. Aisen, J. Cummings, J.R. Sims, J.B. Braunstein, M. Sabbagh, T. Bittner, M. Pontecorvo, S. Bozeat, J.L. Dage, E. Largent, S. Mattke, O. Correa, L.M. Gutierrez Robledo, V. Baldivieso, D.R. Willis, A. Atri, R.J. Bateman, P.-J. Ousset, B. Vellas, M. Weiner

Open source

DOI: 10.14283/jpad.2022.85
Published: 2022-10
Container: The Journal of Prevention of Alzheimer's Disease
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.14283/jpad.2022.85,
  title = {Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force},
  author = {Davide Angioni and J. Delrieu and O. Hansson and H. Fillit and P. Aisen and J. Cummings and J.R. Sims and J.B. Braunstein and M. Sabbagh and T. Bittner and M. Pontecorvo and S. Bozeat and J.L. Dage and E. Largent and S. Mattke and O. Correa and L.M. Gutierrez Robledo and V. Baldivieso and D.R. Willis and A. Atri and R.J. Bateman and P.-J. Ousset and B. Vellas and M. Weiner},
  year = {2022},
  journal = {The Journal of Prevention of Alzheimer's Disease},
  doi = {10.14283/jpad.2022.85},
  url = {https://doi.org/10.14283/jpad.2022.85}
}

RIS

TY  - JOUR
TI  - Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force
AU  - Davide Angioni
AU  - J. Delrieu
AU  - O. Hansson
AU  - H. Fillit
AU  - P. Aisen
AU  - J. Cummings
AU  - J.R. Sims
AU  - J.B. Braunstein
AU  - M. Sabbagh
AU  - T. Bittner
AU  - M. Pontecorvo
AU  - S. Bozeat
AU  - J.L. Dage
AU  - E. Largent
AU  - S. Mattke
AU  - O. Correa
AU  - L.M. Gutierrez Robledo
AU  - V. Baldivieso
AU  - D.R. Willis
AU  - A. Atri
AU  - R.J. Bateman
AU  - P.-J. Ousset
AU  - B. Vellas
AU  - M. Weiner
PY  - 2022
JO  - The Journal of Prevention of Alzheimer's Disease
DO  - 10.14283/jpad.2022.85
UR  - https://doi.org/10.14283/jpad.2022.85
ER  -

APA

Angioni, D., Delrieu, J., Hansson, O., Fillit, H., Aisen, P., Cummings, J., Sims, J., Braunstein, J., Sabbagh, M., Bittner, T., Pontecorvo, M., Bozeat, S., Dage, J., Largent, E., Mattke, S., Correa, O., Robledo, L. G., Baldivieso, V., Willis, D., Atri, A., Bateman, R., Ousset, P., Vellas, B., & Weiner, M. (2022). Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force. The Journal of Prevention of Alzheimer's Disease. https://doi.org/10.14283/jpad.2022.85

Source records

crossref · retrieved 2026-09-25T17:43:27.557Z